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Abstract 
 
Stiffening of the extracellular matrix is a hallmark in cancer progression, embryonic 
development, and wound healing. To mimic this dynamic process, our work explored orthogonal 
enzymatic reactions capable of modulating properties of poly(ethylene glycol) (PEG)-peptide 
hydrogels. A hepta-mutant bacterial transpeptidase Sortase A (SrtA7M) was used to ligate two 
PEG-peptide macromers (i.e., PEG-YLPRTG and NH2-GGGG-PEG) into a primary hydrogel 
network. The hydrogels were dynamically stiffened using mushroom tyrosinase (MT), which 
oxidized tyrosine residues into di-tyrosine and led to increased matrix stiffness. After confirming 
the expression and enhanced catalytic activity of SrtA7M, we investigated the cytocompatibility of 
the enzymatic reaction with a mouse insulinoma cell line, MIN6. In addition, we altered peptide 
substrate concentrations and evaluated their influence on primary hydrogel network properties 
and MT-triggered stiffening. Using a pancreatic cancer cell line, COLO-357, the effect of MT-
triggered stiffening on spheroid formation was investigated. We found that cell spheroids formed 
in hydrogels that were exposed to MT were significantly smaller than spheroids formed without 
MT incubation, suggesting matrix stiffening played a crucial role in the sizes of cancer cell 
spheroids. Through utilizing highly specific and orthogonal enzymatic reactions, this hydrogel 
platform permits rapid and mild in situ cell encapsulation, as well as dynamic control of matrix 
stiffness for investigating the role of matrix stiffening on cell fate processes. 
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1. Introduction 
Hydrogels with dynamically tunable elastic moduli are increasingly being developed to 
mimic matrix stiffening and softening properties of the extracellular matrix (ECM).1-4 Biologically, 
tissue/matrix stiffening plays a significant role during tissue fibrosis and tumor progression.5, 6 
Therefore, designing hydrogels with temporally tunable stiffness will facilitate research concerning 
the influences of matrix stiffening on pathophysiological cell fate processes. Generally, dynamic 
hydrogels are designed to permit secondary crosslinking within the primary cell-laden hydrogel 
network. Utilizing this concept, Burdick and colleagues fabricated methacrylate-functionalized 
hyaluronic acid (MeHA) hydrogels via Michael-type addition reaction between methacrylates and 
thiols with off-stoichiometric ratio.7 Following initial crosslinking, gel stiffening was subsequently 
achieved by inducing light-and-radical-mediated chain growth polymerization of the remaining 
methacrylates. In another example, Suggs et al. utilized infrared radiation (IR) to stiffen alginate-
based hydrogels loaded with temperature-sensitive liposomes containing calcium ions and gold 
nanorods.8 By heating the gold nanorods with IR, calcium ions were released from the disrupted 
liposomes, thus inducing additional crosslinking of alginate chains. Although this system could 
effectively control matrix elasticity both temporally and spatially, the heat generated from IR 
irradiation may not be ideal for certain applications. Gyarmati and Szilágyi demonstrated that time-
dependent disulfide bond formation could be used to induce secondary stiffening of hydrogels.9 
Polymers containing excess free thiols undergo oxidation over time, leading to additional disulfide 
bonds and a stiffened matrix. However, this approach does not afford stringent control over the 
degree of gel stiffening. Disulfide exchange may also destabilize proteins critical to cell fate.  
Anseth et al. showed that PEG-based hydrogels could be reversibly stiffened/softened by 
incorporating a photosensitive azobenzene crosslinker and irradiating with appropriate light.4 
Hydrogel modulus was reversibly tuned (~100-200 Pa) upon azobenzene cis-trans isomerization 
upon UV or visible light exposure. In addition to the use of UV light, another disadvantage was 
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that the magnitude of stiffening was not physiologically relevant. Our lab has utilized host-guest 
interactions to provide physiologically relevant degree of reversible gel stiffening/softening, which 
were achieved by alternate addition and removal of macromolecular adamantane in cyclodextrin 
immobilized gels.10  
In addition to the synthetic approaches described above, biological reactions (e.g., protein 
conformational changes, enzymatic reactions, etc.) have been utilized to modify matrix properties 
in cell-laden hydrogels.11-15 For example, Lutolf et al. prepared HA-based hydrogels by reacting 
HA-glutamine with PEG-Lysine in the presence of transglutaminase,16 which catalyzes the 
isopeptide bond formation between ε-amine of lysine and γ-carboxamide of glutamine. Two 
disadvantages of transglutaminase are its low substrate specificity (i.e., any lysine and glutamine 
residues) and calcium-dependency. Rocasalbas et al. showed that laccase, which catalyzes the 
formation of di-phenol crosslinks, could be used to crosslink phenolic-conjugated gelatin and 
chitosan.17 These gels, however, were formed in approximately two hours, rendering the system 
ineffectual for cell encapsulation. In an attempt to exploit enzymatic reactions for tuning hydrogel 
stiffness, our lab has demonstrated the use of mushroom tyrosinase (MT) to provide 
pathophysiologically relevant dynamic stiffening (G’ from 0.5 kPa to 4 kPa) of cell-laden PEG-
peptide hydrogels.18 Specifically, we used MT to convert network-immobilized tyrosine residues 
into dihydroxyphenylalanine (DOPA) dimers,19 which led to in situ and on-demand matrix 
stiffening. This system was utilized to probe the effect of matrix stiffening on the activation of 
pancreatic stellate cells.18 
Staphylococcus aureus sortase A (SrtA), a transpeptidase with small molecular weight 
(~18-25 kDa) and high substrate specificity, has been widely used in N- and C-terminal labeling 
of proteins,20 peptide cyclization,21 and antibody modification.22, 23 SrtA is a cysteine 
transpeptidase that ligates a short peptide sequence LPXTG (where X is any amino acid but 
proline) and an oligoglycine nucleophile.24 Mechanistically, SrtA cleaves the amide bond between 
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the threonine and glycine residues on LPXTG and forms a thiolacyl intermediate, followed by the 
release of a free glycine segment and the ligation of LPXT with an N-terminal oligolycine 
nucleophile (Fig. 1A). Notably, SrtA-mediated transpeptidation is reversible in the presence of 
additional enzyme and oligoglycine nucleophile. Recently, SrtA has been used to modify 
hydrogels. For example, Griffith and colleagues reported the use of SrtA for modifying biochemical 
properties of synthetic hydrogels and for recovering cells and proteins from gels crosslinked with 
SrtA peptide substrates.14, 25  
To expand the utility of enzyme-based crosslinking and tuning of hydrogel properties, we 
describe here the design of PEG-based hydrogels with orthogonal reactivity for both SrtA and MT. 
Specifically, we optimized SrtA-mediated transpeptidation for rapid crosslinking of PEG-peptide 
hydrogels with conditions suitable for in situ cell encapsulation. We then employed MT for post-
gelation in situ matrix stiffening. To afford orthogonal controls over gelation and stiffening, we 
synthesized two short tri-functional peptides (i.e., CYLPRTG and GGGGC). In addition to the 
sequences as SrtA substrates (i.e., LPRTG-amide and NH2-GGGG-amide), cysteine residues 
were added to permit facile thiol-ene photoclick reaction for conjugating the peptides to 8-arm 
PEG-norbornene (PEG8NB).26 Finally, the inclusion of tyrosine residues rendered the resulting 
gels susceptible to MT-triggered stiffening. We used SrtA7M, a SrtA heptamutant (P94R, E105K, 
E108Q, D160N, D165A, K190E, K196T) with increased catalytic reactivity and independent of 
calcium,27 to fabricate the primary cell-laden hydrogel network. Subsequently, pendant tyrosine 
residues were dimerized upon on-demand incubation with MT. Lastly, we examined the 
cytocompatibility of the dual enzyme responsive gel system and investigated the effect of matrix 
stiffening on cell spheroid formation. 
2. Materials & Methods 
2.1 Materials 
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8-arm PEG-OH (20 kDa) was obtained from JenKem Technology, USA. 5-norbornene-2-
carboxylic acid, N,N’-dicyclohexylcarbodiimide (DCC), 4-(dimethylamino)pyridine (DMAP) 
dimethyl phenylphosphonite, 2,4,6-trimethylbenzoyl chloride, lithium bromide, 2-butanone, and 
diethyl ether were purchased from Sigma-Aldrich. Fmoc-protected amino acids, N,N,N’,N’-
tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU), and 
hydroxybenzotriazole (HOBt) were acquired from AnaSpec or ChemPep. N,N-dimethylformamide 
and dichloromethane were purchased from BDH Chemicals. BL21 E. Coli was purchased from 
New England Biolabs. Kanamycin sulfate was obtained from IBI Scientific. LB agar and broth 
were purchased from DOT Scientific. All other chemicals were obtained from Fisher Scientific 
unless otherwise noted. 
2.2 Macromer Synthesis 
Macromer 8-arm PEG-norbornene (PEG8NB, 20 kDa) was synthesized per established 
protocols with minor modifications.28 In brief, 5-norbornene-2-carboxylic acid (5-fold molar excess 
to hydroxyl group on PEG) was reacted with DCC (2.5x) in anhydrous DCM for 1 hour. The 
resulting product, norbornene anhydride, was transferred to an addition funnel and added drop 
wise to a two necked round bottom flask containing 8-arm PEG-OH, DMAP (0.5x), and pyridine 
(0.5x) under nitrogen. After overnight reaction on ice, the process was repeated to improve 
functionalization of norbornene to PEG. The PEG8NB product was precipitated in cold ethyl ether 
and dried in vacuo. The dried product was re-dissolved in and dialyzed against ddH2O for 3 days 
at room temperature (MWCO 6000-8000), followed by lyophilization. The degree of 
functionalization (ca. 80-90%) was confirmed by 1H NMR (CDCl3, 500 MHz, Bruker Advance 500): 
δ-(4.25 m 2H), 5.98 (m 1H), 6.23 (m 1H) Photoinitiator lithium phenyl-2,4,6-
trimethylbenzoylphosphinate (LAP) was synthesized as described elsewhere.29  
All peptides were synthesized with standard Fmoc coupling chemistry in an automated, 
microwave-assisted peptide synthesizer (Liberty 1, CEM). The crude peptides were cleaved (95% 
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TFA, 2.5% ddH2O, 2.5% TIS, and 5% (w/v) phenol) from resin for 3 hours at room temperature 
and precipitated in cold ethyl ether. The dried, crude peptides were purified using HPLC (Flexar 
System, Perkin Elmer). The purified peptides were confirmed by mass spectrometry (Agilent 
Technologies) and stored at -20oC. 
PEG-peptide conjugates were prepared through reacting purified cysteine-bearing 
peptides with PEG8NB via thiol-norbornene photoclick chemistry. Peptides were dissolved in 
PBS, and Ellman’s assay was performed to determine the concentration of cysteine-bearing 
peptide in solution. The peptides (1.5-fold excess to norbornene groups) were added to a flask 
containing PEG8NB and photoinitiator LAP (5 mM). The mixture was subjected to light (Omnicure 
s1000, 365 nm, 40 mW/cm2) for 30 minutes. At 15 minutes, additional LAP (5 mM) was added to 
improve conjugation efficiency. The PEG-peptide products were dialyzed against ddH2O for 2 
days to remove excess peptides, lyophilized, and stored at -20oC. 
2.3 Heptamutant Sortase A Expression and Purification 
Ca2+-independent, heptamutant sortase A (P94R, E105K, E108Q, D160N, D165A, 
K190E, K196T) was expressed as described previously.30 In brief, competent BL21 E. Coli cells 
were transformed with pet30b-7M SrtA plasmid (a gift from Hidde Ploegh. Addgene plasmid 
#51141). The transformed cells were grown on an LB-agar selection plate containing kanamycin 
(30 µg/mL). An individual colony from the selection plate was picked out and inoculated (220 rpm 
at 37oC) overnight in 10 mL LB media supplemented with kanamycin (30 µg/mL). The culture was 
diluted to 1 L LB media supplemented with kanamycin and shaken at 37oC until the OD600 reached 
0.4-0.8 (~4 hours). Following induction of SrtA7M expression by IPTG (400 µM) for 3 hours, cells 
were isolated by centrifugation (8000 rpm, 15 minutes) and stored at -80oC prior to lysis. Cells 
were lysed by incubating the pellets in lysis buffer (20 mM Tris, 50 mM NaCl, 0.2 mg/mL lysozyme, 
1 mM PMSF, 1x HaltTM EDTA-free protease inhibitor Cocktail, and DNase I) for 30 minutes 
followed by sonication (2 cycles of 3 minutes with 30% duty cycle, 20% amplitude followed by a 
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3 minute cool-down). Lysates were cleared by centrifugation for 20 minutes at 10,000 x g at 4oC 
and purified with His60 Ni Superflow resin and columns per manufacturer’s protocol. The purity 
of the eluted fractions was analyzed by SDS-PAGE and Western Blot with primary antibody 
against 6xhistidine tag. Pure fractions were combined and concentrated to ~50 mg/mL with Ultra-
15 Centrifugal Filter Units (Amicon). Buffer exchange was performed against DPBS with 7k 
MWCO Zeba Spin desalting columns (Thermo Fisher Scientific). Concentrated, desalted SrtA7M 
aliquots were sterile filtered and stored at -80oC. Final SrtA7M concentration was determined using 
Ellman’s assay (SrtA7M contains one free cysteine). SrtA7M activity was verified against SrtAWT 
utilizing the Sensolyte 520 Sortase A activity assay kit (Anaspec Inc.) per the manufacturer’s 
protocol.  
2.4 Sortase A-mediated Hydrogel Crosslinking and Characterization 
Hydrogels were fabricated from conjugating PEG-YLPRTG and NH2-GGGG-PEG with 
specified concentrations of SrtA7M. Both PEG-peptide macromers were dissolved in PBS and 
combined. Gelation was initiated by adding SrtA7M and then proceeded for 10 minutes unless 
otherwise specified. The gels were allowed to swell in PBS at 37oC for 16 hours before measuring 
the hydrogel storage and loss moduli (G’ & G’’) with oscillatory rheometry in strain-sweep mode 
(CVO 100, Bohlin). The reported G’ were averaged from the linear region of the modulus-strain 
curves. In situ rheometry was performed in time sweep mode (0.5% strain, 1 Hz frequency, and 
90 µm gap size at 25oC). Immediately after adding SrtA7M, the precursor solution was mixed and 
pipetted between the rheometer platform and 8 mm parallel plate geometry. To prevent drying, 
the rim of the geometry was sealed with mineral oil.  
2.5 MT Stiffening and Characterization 
Hydrogels were fabricated and incubated in PBS for 16 hours. Using oscillatory rheometry 
in strain-sweep mode as described above, moduli were measured prior to and after hydrogels 
were incubated with MT (1 kU/mL) at 37oC. Due to volumetric shrinkage following MT-triggered 
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stiffening, the gap sizes for RGGGG:LPRTG=1, RGGGG:LPRTG = 3  were reduced from 525 µm to 475 µm 
and 700 µm to 625 µm, respectively.  
2.6 MIN6 and COLO-357 Cell Culture 
MIN6 cells, a mouse insulinoma cell line (a gift from Prof. Raghu Mirmira at IU School of 
Medicine), were maintained in high glucose DMEM (HyClone) containing 10% FBS (Gibco), 1x-
Antibiotic-Antimycotic (Invitrogen, 100 u/mL penicillin, 10 µg/mL streptomycin, and 250 ng/mL 
Fungizone), and 50 µM β-mercaptoethanol. COLO-357 cells, a pancreatic adenocarcinoma cell 
line (a gift from Prof. Murray Korc at IU School of Medicine), were maintained in high glucose 
DMEM  containing 10% FBS, and 1x-Antibiotic-Antimycotic. For both cell lines, media was 
refreshed every 2-3 days.  
2.6 SrtA7M-mediated Encapsulation of MIN6, and Characterization of Cell Viability and 
Morphology 
Prior to encapsulation, cells were trypsinized, counted (Countess® II Automated Cell 
Counter, ThermoFisher), and re-suspended in Hank’s Balanced Salt Solution (HBSS). Re-
suspended cells were mixed with sterile-filtered pre-polymer solution containing desired 
concentrations of PEG-YLPRTG and NH2-GGGG-PEG. Gelation was initiated by adding SrtA7M 
at desired concentration. The cell-polymer solution was immediately transferred to a 1 mL syringe 
mold and cured for 10 minutes to ensure completion prior to placing the hydrogels in fresh media. 
Metabolic activity was monitored with Alamarblue® reagent. In brief, cell-laden gels were 
transferred to Alamarblue® reagent (diluted 10-fold with cell culture media) and incubated for 16 
hours. Following incubation, 200 µL of the diluted media was transferred to a clear 96-well plate 
and the fluorescence was determined by a microplate reader (SynergyHT, Biotek: ex 560 nm em 
590 nm). Additionally, a LIVE/DEAD® staining kit (Life Technologies) was used to assess viability. 
Per the manufacturer’s staining protocol, the hydrogels were placed in PBS diluted with calcein 
AM and an ethidium homodimer and stained for 1 hour. Gels were washed in fresh PBS to remove 
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excess dye, and imaged with a confocal microscope (Olympus Fluoview FV100 laser scanning 
microscope).  
2.7 In Situ MT Stiffening of COLO-357-laden Hydrogels and Characterization of Cell 
Viability and Morphology 
Cell-laden hydrogels were fabricated using SrtA7M as described above. To induce 
secondary stiffening, the cell-laden hydrogels were transferred to a 24-well plate containing media 
supplemented with 1 kU/mL MT and incubated for 6 hrs at 37oC in 5% CO2. The hydrogels were 
transferred to and maintained in a new well containing fresh media. Live/dead staining and 
imaging were performed as described above, and the spheroid diameter was measured using 
Nikon NIS-element software. 
2.8 Statistical Analysis 
Statistical analysis was conducted using a two-tailed t-test or a two-way analysis of 
variance (ANOVA) followed by a Bonferroni’s post-hoc test. A p value < 0.05 was considered 
statistically significant. Single, double, and triple asterisks represent p < 0.05 and 0.01, and 0.001, 
respectively. All studies were performed independently for at least three times and the quantitative 
results were presented are mean ± SEM.    
3.   Results 
3.1 Expression of SrtA7M 
We used heptamutant SrtA (i.e., SrtA7M) in this study for its improved stability and 
enhanced reactivity compared with wild type SrtA (i.e., SrtAWT).31 Successful expression and 
purification of SrtA7M (MW: 18 kDa) was confirmed by SDS-PAGE (Fig. 1B) and Western Blot 
with antibody against 6xhistidine tag (data not shown). The catalytic activity of SrtA7M was verified 
first by comparing enzymatic activity against the commercially available SrtWT in the presence of 
Ca2+. While both enzymes were active in a Ca2+ rich environment (Fig. 1C), SrtA7M exhibited 
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higher catalytic activity than SrtAWT. In a Ca2+ deprived environment (Fig. 1D), SrtAWT completely 
lost its catalytic activity whereas SrtA7M was still active. These data confirm the Ca2+-independent 
catalytic activity of SrtA7M as described in the literature.27, 31, 32  
 
3.2 SrtA7M-mediated crosslinking of PEG-peptide hydrogels 
In order to exploit SrtA7M for hydrogel crosslinking, we prepared PEG-peptide conjugates 
by tethering SrtA substrates (GGGG or LPRTG) to PEG8NB macromers via thiol-norbornene 
reaction (Fig. 2A). Purified peptides bearing cysteine and tyrosine residues (NH2-GGGGC-amide 
or NH2-CYLPRTG-amide) were used to permit thiol-norbornene coupling of the PEG-peptide 
conjugates, which were susceptible to both SrtA7M mediated gel crosslinking and MT-triggered 
stiffening. In situ rheometry was used to determine gelation efficiency at varied concentrations of 
SrtA7M. At a stoichiometric molar ratio of GGGG:LPRTG (RGGGG:LPRTG=1) and total PEG-peptide 
concentration of 2 wt% (i.e., 1 wt% PEG-LPRTG and 1 wt% NH2-GGGG-PEG), the gelation was 
accelerated at higher concentrations of SrtA7M, as indicated by the rapid increases in shear 
modulus (G’, Fig. 2B). As expected, the speed of gelation scaled with SrtA7M concentration. Next, 
we investigated the effect of SrtA7M concentration on the elastic modulus at a fixed total 
concentration of PEG-peptide conjugates (3 wt%, RGGGG:LPRTG=1, Fig. 2C). Gelation was allowed 
to continue for 10 minutes prior to placing the gels in buffer for equilibration (16 hours). Fig. 2C 
shows that SrtA7M concentration did not significantly affect the final moduli of the hydrogels. We 
further determined that 300 µM SrtA7M treatment for 10 minutes was sufficient for complete 
gelation as extending gelation time to 960 minutes only slightly but not statistically increased gel 
moduli (~5,700, ~6,350, and ~6,500 Pa for 10, 60, and 960 minutes gelation, respectively. Fig. 
2D). Finally, the moduli of the hydrogels could be tuned by increasing the total PEG-peptide 
concentration. Specifically, the moduli for 2%, 3%, and 4% of PEG-peptide conjugates were 
~2,700, ~6,000, ~10,000 Pa, respectively (Fig. 2E). 
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3.3 Cytocompatibility of SrtA7M-crosslinked hydrogels  
To evaluate the cytocompatibility of SrtA7M-crosslinked PEG-peptide hydrogels, we 
encapsulated MIN6 β-cells, a particularly vulnerable cell type when encapsulating in bio-inert 
hydrogels at low cell density (<106 cells/mL).33, 34 Similar to results previously reported in 
alternative crosslinking systems,35 the encapsulated cells exhibited increasing metabolic activity 
over the course of the experiment (Fig. 3A). Additionally, live/dead staining images showed that 
virtually all cells remained alive following encapsulation (day 1) and formed spheroids in the 
hydrogels after 10 days of in vitro culture.  
3.4 Dynamic MT stiffening of SrtA7M-crosslinked PEG-peptide hydrogels 
We conferred MT-sensitivity to the SrtA7M-crosslinked hydrogels by simply incorporating 
one tyrosine residue in the peptide crosslinker (Fig. 4A). The primary gel crosslinking was 
achieved by 300 µM SrtA7M treatment of PEG-peptide conjugates. The equilibrated gels were 
placed in buffer containing MT (1 kU/mL) for 3 to 6 hours. As shown in Figure 4B, the moduli of 
hydrogels increased ~1.25-fold and ~1.5-fold after 3 and 6 hours of MT incubation. Secondary 
crosslinking via di-tyrosine formation was evident from the emergence of yellow/brown color in 
the MT-treated gels (Fig. 4C). Specifically, the hydrogels were transparent prior to MT incubation 
but turned yellow and brown after 3 and 6 hours of MT treatment. Additionally, the hydrogels 
underwent volumetric shrinkage and ~25% reduction in diameter after 6 hours of MT incubation. 
These results indicate that inserting a single tyrosine residue into the peptide crosslinker 
successfully rendered the PEG-peptide hydrogels susceptible to not only SrtA7M-mediated 
crosslinking but also MT-triggered in situ stiffening. 
3.5 Optimization of SrtA7M-mediated crosslinking and MT-triggered stiffening 
We varied the substrate ratio (i.e., RGGGG:YLPRTG) at a fixed enzyme concentration so as to 
determine the effect of the substrate concentrations on hydrogel crosslinking. First, hydrogels 
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were fabricated per the formulations in Table 1 with a fixed LPRTG concentration and increasing 
concentrations of GGGG. Intriguingly, PEG-peptide hydrogels containing an equimolar ratio of 
peptide substrates exhibited substantially higher moduli (G’: ~10,000 Pa) than the gels fabricated 
at an RGGGG:YLPRTG= 1/3 (G’ ~1,000 Pa) and 3 (G’: ~1,500 Pa. Fig. 5A). Furthermore, hydrogels 
containing increasing amounts of the nucleophilic oligoglycine (i.e., GGGG) exhibited significantly 
higher gel fraction (0.4, 0.7, and 0.8 for R = 1/3, 1, and 3, respectively). Because of its higher gel 
fraction, we investigated the effect of MT-triggered stiffening on hydrogels fabricated with 
RGGGG:YLPRTG = 3 at two different PEG-peptide concentrations (Fig. 5C). Surprisingly, hydrogels 
composed of 6 wt% and 10 wt% PEG-peptide conjugates (Table 1) exhibited similar initial shear 
moduli of ~1,000 Pa. Upon incubation with MT for 24 hours, the moduli of the 6 wt% hydrogels 
increased to ~2,000 Pa (approximately 2-fold), whereas that of the 10 wt% gels increased to 
~3,000 Pa (approximately 3-fold) due to an increased concentration of the tyrosine residue (Table 
1).  
 
  Table 1. Formulations of PEG-peptide hydrogels used in Figure 5.  
RGGGG:YLPRTG PEG-YLPRTG (wt%) 
NH2-GGGG-PEG 
(wt%) 
Total PEG 
(wt%) 
[YLPRTG] 
(mM) 
[GGGG] 
(mM) 
1/3 1.5 0.5 2 6 2 
1 1.5 1.5 3 6 6 
3 1.5 4.5 6 6 18 
3 2.5 7.5 10 10 30 
 
 
 
3.6 Effect of MT-triggered stiffening on COLO-357 cell viability and spheroid formation 
Owing to its desirable gel fraction and degree of stiffening, we utilized 10 wt% hydrogels 
with an RGGGG:YLPRTG = 3 to encapsulate COLO-357 cells, a pancreatic cancer cell line, to 
investigate the role of dynamic matrix stiffening on cell spheroid formation and morphology. The 
hydrogels were maintained in media and stiffened via MT incubation on D1 post-encapsulation. 
Live/dead staining results show that nearly all cells survived the encapsulation process. By D10, 
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the cells grew into multi-cell spheroids, even though the gels contained no bioactive motif and 
were not proteolytically labile (Fig. 6A). Spheroids formed in gels without MT-triggered stiffening 
were significantly (p < 0.01) smaller than those formed in gels with MT-triggered stiffening (Fig. 
6B). 
4.   Discussion 
Three-dimensional matrices capable of mimicking pathophysiologically relevant ECM 
stiffening are actively developed for tissue engineering applications. Although many approaches 
have been utilized successfully for in vitro cell studies designed to understand the role of matrix 
stiffening on cell fate processes, most require chemical additives, light, heat, and/or do not provide 
stringent control over the rate and magnitude of stiffening. In contrast, enzymatic approaches to 
fabricating and modifying hydrogels are highly specific, predictable, and can occur under mild 
reaction conditions. In this contribution, we explored the use of two enzymes (i.e., SrtA7M and MT) 
with orthogonal reactivity for initial crosslinking and subsequent tuning of PEG-based hydrogel 
properties. PEG-based hydrogels are advantageous due to the high permeability of the network, 
which is critical for facile exchange of nutrients and cellular metabolic wastes.36, 37 Additionally, 
PEG-based hydrogels can be rendered bioactive through the conjugation of short peptide motifs, 
including cell adhesion peptides (e.g. RGDS, YIGSR, etc.) and MMP-cleavable sequences, both 
of which are critical in promoting cell survival and matrix remodeling.38-40  
We rendered the hydrogels susceptible to sequential SrtA7M-mediated crosslinking (Fig. 
2A) and MT stiffening (Fig. 4A) by tethering a single set of peptide substrates (i.e., YLPRTG and 
GGGG) to PEG8NB macromers. SrtA is a bacterial enzyme with high specificity of peptide 
substrates that are absent in nearly all mammalian proteins.25 As a result, the use of SrtA should 
not adversely affect the structure and function of proteins in mammalian cell culture. SrtA and its 
various mutated versions have been increasingly used in bioconjugation chemistry,23, 30 live cell 
labeling,41 and more recently in hydrogel-related applications.14, 25 However, the optimization of 
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SrtA-based transpeptidation in hydrogel fabrication has not been reported. SrtA7M was used here 
as its mutations (P94R/D160N/D165A/K190E/K196T) increased catalytic efficiency (kcat/Km) by 
140-fold)42 and conferred calcium independency (E105K/E108A) due to the stabilization of the 
critical calcium-binding β6/β7 loop.31 We confirmed the SrtA7M expressed for this study was active 
(Fig. 1B) and exhibited high catalytic activity even in Ca2+ deprived solution (Fig. 1C). 
  We optimized the formulations and crosslinking conditions of SrtA7M-mediated primary gel 
crosslinking and characterized MT-catalyzed reactions to obtain a pathophysiologically relevant 
degree of stiffening. Initially, we determined the gelation kinetics with different concentrations of 
enzyme and an equimolar ratio of the peptide substrates (Fig. 2B). As expected, gelation time 
was shorter at higher enzyme concentrations due to an increase in the maximum velocity (Vmax) 
of the transpeptidation reaction. We further characterized the enzymatic crosslinking by 
establishing that gelation could be achieved at low concentrations of SrtA7M (150 µM) (Fig. 2C) 
and a rapid gelation time of 10 minutes (Fig. 2D). Although complete gelation could be achieved 
in 10 minutes at concentrations as low as 150 µM of SrtA7M, we utilized 300 µM of SrtA7M for its 
adequate gel point (~2 minutes) suitable for pipetting, solution mixing, and cell encapsulation. 
Note that the crosslinking density of the hydrogels was highly tunable through adjusting the total 
concentration of the PEG-peptide macromers (Fig. 2E).  
In situ encapsulation of MIN6 β-cells was used to demonstrate the cytocompatibility of the 
SrtA7M-mediated gel crosslinking. MIN6 cells were used because of their sensitivity to cellular 
damages induced by radical-based gel crosslinking.33, 34 The encapsulated cells were alive, and 
proliferated into multicellular spheroids (Fig. 3). This can be attributed to the high substrate 
specificity of the enzymatic reaction, as well as the mild reaction conditions during encapsulation. 
We postulate that SrtA7M can be utilized for encapsulation of a host of mammalian cell lines due 
to these advantages. Although not demonstrated in this work, bioactive moieties, such as RGDS 
or MMP-sensitive peptides, could be incorporated into the hydrogel network using SrtA7M 
transpeptidation, to further enhance survival and function of the cells. 
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Our lab has previously established that the degree of stiffening could be directly controlled 
by adjusting MT incubation time and the number of tyrosine residues on a peptide crosslinker.18 
Here we conferred susceptibility of the SrtA-crosslinked hydrogel network to MT secondary 
stiffening by simply incorporating a tyrosine residue on the peptide crosslinker (Fig. 4A). The di-
tyrosine formed within the SrtA7M-mediated crosslinked hydrogel increased the crosslinking 
density of the hydrogel and hence stiffened the hydrogel (Fig. 4B). The conversion of tyrosine 
residues to di-tyrosine also leads to a color change from transparent to brown further qualitatively 
confirming MT stiffening of the hydrogels (Fig. 4C). As established here, stiffening could be 
achieved “on demand” when the hydrogels are placed in solution containing tyrosinase. 
Additionally, the degree of stiffening could be increased by simply incorporating additional 
residues in the peptide substrates (i.e. YLPRTG and GGGGY); however, our results suggest that 
the incorporation of a single tyrosine residue is sufficient for inducing pathophysiologically relevant 
magnitudes of stiffening. 
 The inherent reversibility of the transpeptidation reaction is a notable drawback of utilizing 
SrtA7M. This is due the cleaved glycine-containing by-products also serve as substrates for 
additional transpeptidation.43 In solution with low glycine content, the thioacyl LPXT-SrtA7M 
intermediate can be hydrolyzed rendering the substrate unreactive.43 To mitigate these potentially 
undesirable side reactions, researchers often employ excess oligoglycine to the LPXTG substrate 
or have designed substrates with unreactive cleavage byproducts.44-46 We sought to investigate 
SrtA7M-crosslinking in the presence of different ratios of the substrates, PEG-LPRTG and PEG-
GGGG (Figs. 5A, B) and found that the concentration of the oligoglycine substrate plays a 
significant role in determining the mechanical properties of the hydrogels. Hydrogels fabricated 
with RGGGG:LPRTG=1 yielded a significantly stiffer matrix suggesting that an equimolar ratio of the 
substrates yielded a hydrogel network with less structural defects. The softer hydrogel at low 
concentrations of GGGG (RGGGG:YLPRTG = 1/3) also exhibited a lower gel fraction (Figs. 5A, B) 
likely due to the loss of unreacted PEG-LPRTG macromer. While a three-fold excess of GGGG 
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(RGGGG:YLPRTG = 3) also produced a softer matrix, the gel fraction was comparable to the gels 
formed at stoichiometric ratio (Figs. 5A, B). We speculate that an excess of unreacted PEG-
GGGG arms created network defects similar to the hydrogels fabricated with RGGGG:YLPRTG = 1/3; 
however, additional oligoglycine substrate drove the reaction towards transpeptidation, hence 
yielding an increased gel fraction. Due to its higher gel fraction, we explored the effect of MT 
stiffening on hydrogels with RGGGG:YLPRTG = 3 at different total concentrations of PEG (Fig. 5C). At 
both 6 wt% and 10 wt% of total PEG-peptide concentrations, the initial shear modulus was similar. 
We postulate that at constant Vmax for both conditions, additional time is required for SrtA7M to 
consume the substrate and therefore to reach complete gelation for the 10 wt% hydrogels. 
Moreover, we observed a greater degree of stiffening in the 10 wt% hydrogels due to a higher 
concentration of tyrosine residues (Fig. 5C).   
Future investigations are required to further elucidate the role of the substrate ratio on 
SrtA7M reactions and hydrogel crosslinking kinetics. However, due to its desirable gel fraction, 
initial modulus, and physiologically relevant magnitude of stiffening (from ~1 to 3 kPa, Fig. 5C), 
we utilized 10 wt% hydrogels with RGGGG:YLPRTG = 3 for encapsulation of pancreatic cancer cells to 
investigate the effect of MT stiffening on cell spheroid formation. The color change, which did not 
interfere with confocal imaging, confirmed secondary stiffening of cell-laden hydrogels.  Note that 
these gels were crosslinked without protease sensitive motifs, thus enabling the study of dynamic 
matrix stiffening on cell spheroids formation without the complication of cell-mediated proteolytic 
gel degradation. Clearly, stiffening of the hydrogels inhibited cell proliferation as indicated by the 
smaller spheroids (Figure 6). This is consistent with our previous report exploring the effect of 
matrix stiffness on COLO-357 cell spheroid sizes.47 This can be attributed to the increased density 
of the polymer network. Notably, both initial crosslinking and subsequent stiffening occurred 
without causing cell damage. While the MT-triggered stiffening process were performed for only 
6 hours, the duration by which gels were stiffened could be extended to multiple days to closely 
mimic in vivo stiffening of tissues. This demonstrates the efficacy of the dual enzymatic 
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crosslinking strategy for controlling the morphology of pancreatic cancer cells. Moreover, this 
system could be utilized to generate spheroids of various cell types in 3D. The inherent 
reversibility of SrtA7M transpeptidation should allow for site specific degradation of the hydrogels.25 
Therefore, future experiments may be focused on generation and recovery of tumor spheroids for 
further functional and biological characterizations. Although protease sensitive crosslinkers were 
not incorporated into the hydrogels in the current study, future work may include the addition of 
bioactive peptides to allow for cell-driven degradation. For example, a peptide linker could be 
synthesized with NH2-GGG followed by a protease-sensitive sequence, such as matrix 
metalloproteinase (MMP) cleavable peptide GPQGIWGQ. MMP-sensitive sequence could also 
be placed before LPRTG. After SrtA-mediated gelation, hydrogel crosslinks would become PEG-
LPRTGGGGPQGIWGQ-PEG or PEG-GPQGIWGQLPRTGGG-PEG, both of which will be 
susceptible to MMP-mediated cleavage. 
 
5.   Conclusion 
In summary, we have developed a purely enzymatic strategy for hydrogel crosslinking and 
on-demand stiffening. The specificity of the substrates allows for rapid SrtA7M-mediated 
crosslinking, whereas the incorporation of a single tyrosine residue into the peptide crosslinker 
warrants highly controllable hydrogel stiffening. Due to the specificity of the substrates as well as 
the mild reaction conditions, SrtA7M-mediated crosslinking was highly cytocompatible even for a 
sensitive cell type (i.e., MIN6). The crosslinking and subsequent stiffening of the hydrogels could 
be optimized by adjusting the concentrations of the PEG-peptides. Finally, stiffening of cell-laden 
hydrogels inhibited cell spreading effectively controlling the formation and morphology of cell 
spheroids. Future work will include further optimization of the SrtA7M crosslinking strategy as well 
as exploiting this system for investigating the underlying mechanisms of cellular response to a 
stiffening microenvironment. 
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Figure 1. (A) Mechanism of SrtA-mediated transpeptidation. Cysteine residue at the active center 
of SrtA recognizes the amide bond between T and G residues of the conserved LPXTG motif, 
forming a thioacyl intermediate. The intermediate is resolved following the attack of an amino 
oligoglycine nucleophile, yielding the final product (i.e., LPXTGGGG) and regenerating SrtA. (B) 
SDS-PAGE of SrtA7M (~18 kDa) expressed in BL21 E. Coli. SrtAWT and SrtA7M activity in Tris-HCl 
(pH = 8.0) with 50 nM SrtA, 2 µM 5-FAM/QXL FRET peptide substrate, and 2 mM of oligo-glycine 
peptide (i.e., GGGGC) in the presence (C) or absence (D) of 10 mM CaCl2. SrtA induced substrate 
cleavage was detected by fluorescence of the cleaved 5-FAM substrate (excitation/emission = 
490/520). RFU: relative fluorescence units. 
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Figure 2. (A) Schematic of SrtA7M-mediated hydrogel crosslinking. (B) In situ rheometry of PEG-
peptide (2 wt%, RGGGG:LPRTG = 1) hydrogel crosslinking. (C) Influence of SrtA7M concentration on 
the modulus of PEG-peptide hydrogels (3 wt%, RGGGG:LPRTG = 1) after 10 minutes of gelation. (D) 
Influence of gelation time on the modulus of PEG-peptide hydrogels (3 wt%, RGGGG:LPRTG = 1) with 
300 µM SrtA7M. (E) Influence of PEG-peptide concentration on the modulus with 10 minutes of 
gelation time and 300 µM SrtA7M.    
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Figure 3. (A) Effect of SrtA7M-mediated crosslinking on the metabolic activity of encapsulated 
MIN6 cells (n=3). (B) Representative confocal z-stack images of live/dead stained MIN6 cells 
encapsulated in PEG-peptide hydrogels. Cells were encapsulated at 2x106 cells/ml in PEG-
peptide hydrogels (3 wt%, RGGGG:LPRTG = 1) and imaged on D1 and D10 post-encapsulation. At 
least three z-stacked images per gel (100 µm thick, 10 slices) were taken. 
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Figure 4. (A) Schematic of MT-triggered secondary crosslinking. (B) Influence of MT incubation 
time on the modulus of PEG-peptide hydrogels (2 wt%, RGGGG:LPRTG = 1, MT = 1 kU/mL). (C) 
Representative images of hydrogels incubated with MT for varying duration.  
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Figure 5. (A) Influence of RGGGG:LPRTG on hydrogel modulus. The gap sizes utilized for RGGGG:LPRTG 
=1/3, RGGGG:LPRTG =1, RGGGG:LPRTG = 3 were 475 µm, 525 µm, and 700 µm, respectively. (B) 
Influence of RGGGG:LPRTG on gel fraction. (C) MT-triggered stiffening of PEG-peptide hydrogels 
(RGGGG:LPRTG = 3). 
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Figure 6. (A) Day 1 and Day 10 live/dead images of encapsulated COLO-357 cells (2x106 
cells/mL) with and without 6 hour incubation with MT (1 kU/mL). At least three z-stacked images 
per gel (100 µm thick, 10 slices) were taken. (B) Distribution of cell spheroids diameters with or 
without MT-triggered stiffening. Spheroid sizes were quantified using live/dead staining images at 
10-days post-encapsulation. The diameter of spheroids with and without MT-triggered stiffening 
were 45.91 ± 0.67 µm (n = 594) and 39.48 ± 0.51 µm (n = 590), respectively. A two-tailed t-test 
was performed for statistical analysis (p < 0.01).  
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